Elevated Plasma Complement Proteins in Palmoplantar Pustulosis: A Potential Therapeutic Target

Abstract

Keywords

palmoplantar pustulosis inflammatory biomarker complement C3a C5a C5b-9

Get full access to this article

View all access options for this article.

References

Bissonnette

Nigen

Langley

et al. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol. 2014;28(10):1298-1305.doi:10.1111/jdv.12272

24112799

Ghias

MH.

Hyde

MJ.

Tomalin

et al. Role of the complement pathway in inflammatory skin diseases: a focus on hidradenitis suppurativa. J Invest Dermatol. 2020;140(3):531-536.doi:10.1016/j.jid.2019.09.009

31870626

Wang

Suárez-Fariñas

Estrada

et al. Identification of unique proteomic signatures in allergic and non-allergic skin disease. Clin Exp Allergy. 2017;47(11):1456-1467.doi:10.1111/cea.12979

28703865

Kanni

Zenker

Habel

Riedemann

Giamarellos-Bourboulis

. Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? Br J Dermatol. 2018;179(2):413-419.doi:10.1111/bjd.16428

29405257

Laudisi

Spreafico

Evrard

et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol. 2013;191(3):1006-1010.doi:10.4049/jimmunol.1300489

23817414